// App-Quantinova.ai

POS0198 (2022) : COVID-19 OUTCOMES IN PATIENTS WITH DERMATOMYOSITIS: A REGISTRY-BASED COHORT ANALYSIS

Researchers

Presenter

  • L. Gupta

Principal Investigators

  • H. Pakhchanian

  • H. Khan

  • R. Raiker

  • M. Abbasi

  • C. Deyoung

  • S. Kardes

  • S. Ahmed

  • C. Kavadichanda

  • P. Sen

  • R. Aggarwal

Medical Centers

  • Royal Wolverhampton NHS Trust, Department of Rheumatology, Wolverhampton, United Kingdom

  • Sanjay Gandhi Postgraduate Institute of Medical Sciences, Clinical Immunology and Rheumatology, Lucknow, Uttar Pradesh, India

  • George Washington University, School of Medicine and Health Sciences, Washington DC, United States of America

  • Dubai Medical College Dubai United Arab Emirates

  • West Virginia University School of Medicine, Surgery, Charleston, United States of America

  • Sidney Kimmel Medical College at Thomas Jefferson University, -, Philadelphia, United States of America

  • Istanbul University Faculty of Medicine, Department of Medical Ecology and Hydroclimatology, Istanbul, Turkey

  • Kalinga Institute of Medical Sciences, Department of Clinical Immunology and Rheumatology, Bhubaneswar, India

  • Jawaharlal Institute of Postgraduate Medical Education and Research, Department of Clinical Immunology, Puducherry, India

  • Maulana Azad Medical College, Pediatrics, New Delhi, India

  • University of Pittsburgh, Department of Medicine, Rheumatology and Clinical Immunology, Pittsburgh, United States of America

Locations

  • United Kingdom

  • India

  • United States

  • United Arab Emirates

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Nephrology

  • Infectious Diseases (ID)

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

  • Genetic Disorder

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Oncology (ONC)

Disease

  • Acute lung injury

  • Venous thrombosis

  • Acute renal failure

  • Juvenile dermatomyositis

  • Ischemic stroke

  • Coronavirus disease

  • Solid malignancies

  • Stroke

  • Sepsis

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A